Table 5.
bacterial | number of antibioticsa × 2 | Africa | Asia | Europe | North America | Latin America |
---|---|---|---|---|---|---|
E. coli | 14 | 7 (50.0) | 4 (28.6) | 0 (0.0) | 0 (0.0) | 3 (14.3) |
K .pneumoniae | 16 | 8 (50.0) | 0 (0.0) | 3 (18.8) | 0 (0.0) | 5 (31.3) |
S. marcescens | 6 | 2 (33.1) | 1 (16.7) | 0 (0.0) | 2 (33.3) | 1 (16.7) |
E. cloacae | 16 | 5 (31.3) | 6 (37.5) | 2 (12.5) | 0 (0.0) | 3 (18.8) |
P. aeruginosa | 10 | 1 (10.0) | 3 (30.0) | 4 (40.0) | 0 (0.0) | 2 (20.0) |
A. baumannii | 16 | 7 (43.8) | 1 (6.3) | 1 (6.3) | 0 (0.0) | 7 (43.8) |
S. aureus | 4 | 2 (50.0) | 2 (50.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
E. faecalis | 4 | 2 (50.0) | 0 (25.0) | 1 (25.0) | 1 (25.0) | 0 (0.0) |
E. faecium | 11b | 2b(18.2) | 2 (18.2) | 2b(18.2) | 2 (18.2) | 3 (27.3) |
S. pneumoniae | 14 | 2 (14.3) | 7 (50.0) | 0 (0.0) | 2 (14.3) | 3 (21.4) |
Total | 111 | 38 (34.2) | 26 (23.4) | 13 (11.7) | 7 (6.3) | 27 (24.3) |
a There were antibiotics with a global susceptibility of less than 90%
b Same susceptibility in Africa and Europe of ampicillin to E. faecium